Literature DB >> 4116781

A cholinergic-adrenergic hypothesis of mania and depression.

D S Janowsky, M K el-Yousef, J M Davis, H J Sekerke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4116781     DOI: 10.1016/s0140-6736(72)93021-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  179 in total

1.  Lithium administration antagonizes cholinergic behavioral effects in rodents.

Authors:  D S Janowsky; A A Abrams; G P Groom; L L Judd; P Cloptin
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

2.  Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance.

Authors:  H Anisman; G Remington; L S Sklar
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

3.  The effect of tricyclic antidepressants on cholinergic responses of single cortical neurones.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

Review 4.  Cholinesterase inhibitors for behavioral disturbance in dementia.

Authors:  E J Daly; W E Falk; P Brown
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

5.  Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity.

Authors:  Li-Fang Yu; Werner Tückmantel; J Brek Eaton; Barbara Caldarone; Allison Fedolak; Taleen Hanania; Dani Brunner; Ronald J Lukas; Alan P Kozikowski
Journal:  J Med Chem       Date:  2012-01-04       Impact factor: 7.446

6.  Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL/6J mice.

Authors:  Yann S Mineur; Tenna N Mose; Sam Blakeman; Marina R Picciotto
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

7.  Historical studies of premenstrual tension up to 30 years ago: implications for future research.

Authors:  David S Janowsky; Jeffrey L Rausch; John M Davis
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

8.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

9.  Effects of mianserin in neuroleptic-induced parkinsonism.

Authors:  S Korsgaard; T Friis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity.

Authors:  D W Gallager; W E Bunney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.